Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niko P Bretz

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Neurobiology of Disease|December 21, 2016
The CD24 surface antigen in neural development and diseaseDaniel T Gilliam, Vishal Menon, Niko P Bretz, et al.
Seminars in Cancer Biology|April 29, 2014
Novel insights into exosome-induced, tumor-associated inflammation and immunomodulationPeter Altevogt, Niko P Bretz, Johannes Ridinger, et al.
International Journal of Cancer|September 19, 2014
Antibody therapy to human L1CAM in a transgenic mouse model blocks local tumor growth but induces EMTKai Doberstein, Patrick N Harter, Uwe Haberkorn, et al.
Cancer Letters|August 24, 2014
miR-21-3p is a positive regulator of L1CAM in several human carcinomasKai Doberstein, Niko P Bretz, Uwe Schirmer, et al.
Immunology Letters|June 24, 2014
Lack of CD24 expression in mice reduces the number of leukocytes in the colonNiko P Bretz, Alexei V Salnikov, Kai Doberstein, et al.
Cellular and Molecular Life Sciences : CMLS|July 5, 2012
CD24 controls Src/STAT3 activity in human tumorsNiko P Bretz, Alexei V Salnikov, Claudia Perne, et al.
The Journal of Biological Chemistry|November 15, 2013
Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signalingNiko P Bretz, Johannes Ridinger, Anne-Kathleen Rupp, et al.
BMC Cancer|December 17, 2014
L1CAM is expressed in triple-negative breast cancers and is inversely correlated with androgen receptorKai Doberstein, Karin Milde-Langosch, Niko P Bretz, et al.
Oncotarget|February 6, 2014
Role of miR-34a as a suppressor of L1CAM in endometrial carcinomaUwe Schirmer, Kai Doberstein, Anne-Kathleen Rupp, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Neurobiology of Disease|December 21, 2016
The CD24 surface antigen in neural development and diseaseDaniel T Gilliam, Vishal Menon, Niko P Bretz, et al.
Seminars in Cancer Biology|April 29, 2014
Novel insights into exosome-induced, tumor-associated inflammation and immunomodulationPeter Altevogt, Niko P Bretz, Johannes Ridinger, et al.
International Journal of Cancer|September 19, 2014
Antibody therapy to human L1CAM in a transgenic mouse model blocks local tumor growth but induces EMTKai Doberstein, Patrick N Harter, Uwe Haberkorn, et al.
Cancer Letters|August 24, 2014
miR-21-3p is a positive regulator of L1CAM in several human carcinomasKai Doberstein, Niko P Bretz, Uwe Schirmer, et al.
Immunology Letters|June 24, 2014
Lack of CD24 expression in mice reduces the number of leukocytes in the colonNiko P Bretz, Alexei V Salnikov, Kai Doberstein, et al.
Cellular and Molecular Life Sciences : CMLS|July 5, 2012
CD24 controls Src/STAT3 activity in human tumorsNiko P Bretz, Alexei V Salnikov, Claudia Perne, et al.
The Journal of Biological Chemistry|November 15, 2013
Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signalingNiko P Bretz, Johannes Ridinger, Anne-Kathleen Rupp, et al.
BMC Cancer|December 17, 2014
L1CAM is expressed in triple-negative breast cancers and is inversely correlated with androgen receptorKai Doberstein, Karin Milde-Langosch, Niko P Bretz, et al.
Oncotarget|February 6, 2014
Role of miR-34a as a suppressor of L1CAM in endometrial carcinomaUwe Schirmer, Kai Doberstein, Anne-Kathleen Rupp, et al.
Pageof 1